Cargando…

Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension

BACKGROUND: Hypertension occurred in 30–80% of Takayasu arteritis (TAK) patients around the world and the occurrence of hypertension might worsen the disease prognosis. This study aimed to investigate the clinical characteristics and imaging phenotypes, as well as their associations with events free...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Sun, Sifan, Wu, Yujiao, Wang, Rongyi, Chen, Qingrong, Huang, Lili, Ma, Huiyong, Chen, Lindi, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293580/ https://www.ncbi.nlm.nih.gov/pubmed/34289874 http://dx.doi.org/10.1186/s13075-021-02579-8

Ejemplares similares

Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis
por: Wu, Chunling, et al.
Publicado: (2020)

Risk factors of aortic regurgitation progression in Chinese patients with Takayasu’s arteritis: a prospective cohort study
por: Wang, Yujiao, et al.
Publicado: (2022)

Augmented PFKFB3-mediated glycolysis by interferon-γ promotes inflammatory M1 polarization through the JAK2/STAT1 pathway in local vascular inflammation in Takayasu arteritis
por: Chen, Rongyi, et al.
Publicado: (2022)

Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China
por: Kong, Xiufang, et al.
Publicado: (2020)

Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
por: Ying, Sun, et al.
Publicado: (2020)

Serum leptin, a potential predictor of long‐term angiographic progression in Takayasu’s arteritis
por: Ma, Lili, et al.
Publicado: (2019)

Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis
por: Kong, Xiufang, et al.
Publicado: (2021)

Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis
por: Chen, Rongyi, et al.
Publicado: (2021)

Biomarker Changes and Molecular Signatures Associated with Takayasu Arteritis Following Treatment with Glucocorticoids and Tofacitinib
por: Dai, Xiaojuan, et al.
Publicado: (2022)

A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with Takayasu arteritis
por: Kong, Xiufang, et al.
Publicado: (2022)

Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC)
por: Sun, Ying, et al.
Publicado: (2023)

Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu’s arteritis: an observational study
por: Dai, Xiaomin, et al.
Publicado: (2020)

Takayasu Arteritis
por: Russo, Ricardo A. G., et al.
Publicado: (2018)

Hypoperfusive and hypertensive ocular manifestations in Takayasu arteritis
por: Peter, Jayanthi, et al.
Publicado: (2010)

Secondary Hypertension Due to Underlying Takayasu Arteritis
por: Raja, Ahmad, et al.
Publicado: (2022)

Takayasu arteritis in children
por: Al abrawi, Safia, et al.
Publicado: (2008)

Takayasu's arteritis in childhood
por: Brunner, J
Publicado: (2008)

Takayasu arteritis in an infant
por: Sandeep, S., et al.
Publicado: (2014)

Scleritis in Takayasu Arteritis
por: Chittipolu, Swetha, et al.
Publicado: (2023)

Takayasu Arteritis with Dyslipidemia Increases Risk of Aneurysm
por: Pan, Lili, et al.
Publicado: (2019)

Ultra-widefield imaging in Takayasu arteritis
por: Das, Manmath K, et al.
Publicado: (2022)

Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022)

Echocardiographic characteristics of pulmonary artery involvement in Takayasu arteritis
por: Jiang, Wei, et al.
Publicado: (2017)

Takayasu arteritis and hyperthyroidism: A secondary hypertension case report
por: He, Lian-Man, et al.
Publicado: (2023)

Surgical Management of Takayasu's Arteritis
por: Joh, Jin-Hyun, et al.
Publicado: (2006)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

Bentall procedure in Takayasu arteritis
por: Hidiroglu, M, et al.
Publicado: (2013)

Recurrent Vertigo: Is it Takayasu's Arteritis?
por: Ashutosh, Tiwari, et al.
Publicado: (2013)

5. Paediatric Takayasu arteritis
por: Mackay, Madeleine, et al.
Publicado: (2018)

“Macaroni Sign” in Takayasu Arteritis
por: Ghembaza, Mohammed El Amine, et al.
Publicado: (2018)

Intracranial Involvement in Takayasu’s Arteritis
por: Johnson, Andrea, et al.
Publicado: (2021)

Novel Therapies in Takayasu Arteritis
por: Regola, Francesca, et al.
Publicado: (2022)

Takayasu Arteritis Mimicking Phlegmon
por: Taira, Yuki, et al.
Publicado: (2022)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Pulmonary artery involvement in Takayasu’s arteritis: diagnosis before pulmonary hypertension
por: Yang, Jing, et al.
Publicado: (2019)

Renovascular hypertension secondary to Takayasu's arteritis in a child: Case report
por: Souza Magalhães, Ricardo Filipe, et al.
Publicado: (2022)

Disease-specific factors associated with cardiovascular events in patients with Takayasu arteritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Arteritis de takayasu y embarazo
por: Fuertes Isasmendi, Purificación
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_dj3at0qnh6pp7bb29bkte83te9